The European Technology Platform on Nanomedicine (ETPN) invites its members to partake in a scientific initiative by the FDA/ASTM International Committee E56 on Nanotechnology. The committee is conducting Interlaboratory Studies to assess the precision and bias of liposomal lipid quantitation methods. This initiative offers participating labs the chance to contribute to nanomedicine’s evolution, particularly in relation to standardization and metrological needs. The ETPN also highlights the upcoming launch of the MetrINo project, an innovative European endeavor set to contribute significantly to the Nanomed Europe 2023 conference and the broader nanomedicine landscape.